Now showing items 1-5 of 5
Subtipos moleculares del cáncer de mama: implicaciones pronósticas y características clínicas e inmunohistoquímicas
(Gobierno de Navarra, 2011) Artículo / Artikulua,
Fundamento. Los carcinomas de mama representan un grupo heterogéneo de tumores, tanto en su comportamiento clínico como pronóstico. El objetivo del presente trabajo es clasificar los carcinomas de mama en subtipos ...
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
(BioMed Central, 2017) info:eu-repo/semantics/article,
Background: Cadherin-like protein 22 (CDH22) is a transmembrane glycoprotein involved in cell-cell adhesion and metastasis. Its role in cancer is controversial because it has been described as being upregulated in ...
Relationship between handgrip strength and muscle mass in female survivors of breast cancer: a mediation analysis
(MDPI, 2017) info:eu-repo/semantics/article,
This study explored the mediating factors of sarcopenia in a group of women survivors of breast cancer in Bogotá, Colombia. This was a descriptive cross-sectional study with 98 women survivors of breast cancer, who were ...
The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis
(BioMed Central, 2016) info:eu-repo/semantics/article,
Background: Insulin-like growth factors (IGF´s) play a crucial role in controlling cancer cell proliferation, differentiation and apoptosis. Exercise has been postulated as an effective intervention in improving ...
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
(Impact Journals, 2017) info:eu-repo/semantics/article,
The CHL1 gene encodes a cell-adhesion molecule proposed as being a putative tumour-suppressor gene in breast cancer (BC). However, neither the underlying molecular mechanisms nor the clinical value of CHL1 downregulation ...